• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Biodesix, Inc. - Common Stock (NQ:BDSX)

    10.98 +1.14 (+11.59%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 30, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 101,820
    Open 9.760
    Bid (Size) 9.620 (100)
    Ask (Size) 14.67 (300)
    Prev. Close 9.840
    Today's Range 9.760 - 11.39
    52wk Range 3.436 - 20.21
    Shares Outstanding 78,614,114
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    Biodesix Recognized as a Top Workplace for Third Consecutive Year
    Employee-Driven, Prestigious National Recognition for the Consistently High-Performing Biodesix Culture 
    From Biodesix, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +70.0%
    +70.0%
    1 Month
    -20.4%
    -20.4%
    3 Month
    +6.3%
    +6.3%
    6 Month
    +67.9%
    +67.9%
    1 Year
    +2.5%
    +2.5%

    More News

    Read More
    News headline image
    Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    Biodesix (BDSX) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    Biodesix Inc (NASDAQ:BDSX) Reports Q4 2025 Earnings Beat and First Adjusted EBITDA Profitability ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    Biodesix to Participate in Upcoming Investor Conferences
    From Biodesix, Inc.
    Via GlobeNewswire
    BDSX Stock Shot Up 23% Pre-Market Today — What’s Fueling The Surge? ↗
    Via Stocktwits
    News headline image
    Earnings Scheduled For November 3, 2025 ↗
    Via Benzinga
    News headline image
    What's Next: Biodesix's Earnings Preview ↗
    Via Benzinga
    News headline image
    Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
    From Biodesix, Inc.
    Via GlobeNewswire
    Which stocks are moving on Wednesday? ↗
    Via Chartmill
    Curious about the stocks that are showing activity after the closing bell on Monday? ↗
    Via Chartmill
    News headline image
    Biodesix Shares Rocket 42% on Record FY2025 Results and Path to Profitability
    Via MarketMinute
    Topics Artificial Intelligence Death
    News headline image
    Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited)
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    Biodesix to Present New Data at Two Major Upcoming Scientific Meetings
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
    Via Benzinga
    News headline image
    Biodesix Announces Third Quarter 2025 Results and Highlights
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting
    From Biodesix, Inc.
    Via GlobeNewswire
    News headline image
    Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit
    From Biodesix, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Biodesix, Inc. - Common Stock publicly traded?
    Yes, Biodesix, Inc. - Common Stock is publicly traded.
    What exchange does Biodesix, Inc. - Common Stock trade on?
    Biodesix, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Biodesix, Inc. - Common Stock?
    The ticker symbol for Biodesix, Inc. - Common Stock is BDSX on the Nasdaq Stock Market
    What is the current price of Biodesix, Inc. - Common Stock?
    The current price of Biodesix, Inc. - Common Stock is 10.98
    When was Biodesix, Inc. - Common Stock last traded?
    The last trade of Biodesix, Inc. - Common Stock was at 04/30/26 04:00 PM ET
    What is the market capitalization of Biodesix, Inc. - Common Stock?
    The market capitalization of Biodesix, Inc. - Common Stock is 863.18M
    How many shares of Biodesix, Inc. - Common Stock are outstanding?
    Biodesix, Inc. - Common Stock has 863M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.